Endoscopic Postoperative Recurrence In Crohn's Disease After Curative Ileocecal Resection With Early Prophylaxis By Anti-Tnf, Vedolizumab Or Ustekinumab A Real-World Multicenter European Study /

Hasonló tételek

• Curative oncological therapy in cervical cancer
  Szerző: Kahán Zsuzsanna, et al.
• Ünnepelték Curát és a Toscát
  Szerző: Puccini, Giacomo
  Megjelent: (2009)
• Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn’s disease results from a multicentre cohort study /
  Szerző: Bacsur Péter, et al.
  Megjelent: (2022)
• Which patients would benefit from antibiotic prophylaxis a "burning" question? /
  Szerző: Hankovszky Péter, et al.
  Megjelent: (2016)
• Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate a randomized clinical trial (TRANSIT) /
  Szerző: Paul Carle, et al.
  Megjelent: (2014)